Nuclear translocation of beta II PKC isoenzyme in phorbol ester-stimulated KM-3 pre-B human leukemic cells

O Trubiani1, R A Rana, L Stuppia

  • 1Istituto di Morfologia Umana Normale, Facoltà di Medicina, Università di Chieti, Italy.

Insights

Protein Kinase C (PKC) isoforms regulate cell growth. In human B lymphocytes, phorbol 12-myristate 13-acetate (PMA) causes the beta II PKC isoform to move into the nucleus, suggesting a role in gene regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Protein Kinase C (PKC) family regulates cell growth and differentiation.
  • Specific functions of PKC isoforms and their substrate specificity are not fully understood.
  • PKC plays a role in intracellular signaling pathways.

Purpose of the Study:

  • Investigate PKC isoform expression and modulation in KM-3 human pre-B cells.
  • Examine the effects of phorbol 12-myristate 13-acetate (PMA) on PKC isoforms.
  • Determine the role of differential isoenzyme expression in B lymphocyte signaling.

Main Methods:

  • Multiparametric analysis to detect PKC isoforms in KM-3 cells.
  • Treatment of KM-3 cells with phorbol 12-myristate 13-acetate (PMA).
  • Analysis of protein and messenger RNA levels of PKC isoforms.

Main Results:

  • Three PKC isoforms (alpha, beta II, and zeta) were detected in KM-3 cells.
  • PMA treatment induced intranuclear translocation of the beta II PKC isoform.
  • The beta II isoform translocated via the nuclear pore complex to interchromatinic regions.

Conclusions:

  • The beta II PKC isoform is present in human pre-B cells.
  • PMA treatment modulates the localization of the beta II PKC isoform.
  • The beta II isoenzyme may be crucial for signal transduction and gene expression regulation in B lymphocytes.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...